BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 11706924)

  • 1. Commonly used antibacterial and antifungal agents for hospitalised paediatric patients: implications for therapy with an emphasis on clinical pharmacokinetics.
    Singh J; Burr B; Stringham D; Arrieta A
    Paediatr Drugs; 2001; 3(10):733-61. PubMed ID: 11706924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacodynamics of antibacterials, antifungals, and antivirals used most frequently in neonates and infants.
    Roberts JK; Stockmann C; Constance JE; Stiers J; Spigarelli MG; Ward RM; Sherwin CM
    Clin Pharmacokinet; 2014 Jul; 53(7):581-610. PubMed ID: 24871768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of antibacterial agents in the CSF of children and adolescents.
    Sullins AK; Abdel-Rahman SM
    Paediatr Drugs; 2013 Apr; 15(2):93-117. PubMed ID: 23529866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic optimisation of the treatment of bacterial central nervous system infections.
    Nau R; Sörgel F; Prange HW
    Clin Pharmacokinet; 1998 Sep; 35(3):223-46. PubMed ID: 9784935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis.
    Roberts JA; Lipman J
    Clin Pharmacokinet; 2006; 45(8):755-73. PubMed ID: 16884316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacokinetics of antibacterial drugs in neonates.
    Paap CM; Nahata MC
    Clin Pharmacokinet; 1990 Oct; 19(4):280-318. PubMed ID: 2208898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
    Zhanel GG; Golden AR; Zelenitsky S; Wiebe K; Lawrence CK; Adam HJ; Idowu T; Domalaon R; Schweizer F; Zhanel MA; Lagacé-Wiens PRS; Walkty AJ; Noreddin A; Lynch Iii JP; Karlowsky JA
    Drugs; 2019 Feb; 79(3):271-289. PubMed ID: 30712199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceftobiprole: a review of a broad-spectrum and anti-MRSA cephalosporin.
    Zhanel GG; Lam A; Schweizer F; Thomson K; Walkty A; Rubinstein E; Gin AS; Hoban DJ; Noreddin AM; Karlowsky JA
    Am J Clin Dermatol; 2008; 9(4):245-54. PubMed ID: 18572975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibacterial-induced nephrotoxicity in the newborn.
    Fanos V; Cataldi L
    Drug Saf; 1999 Mar; 20(3):245-67. PubMed ID: 10221854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Investigation on the rational use of antibacterial agents by Chinese pediatricians in 2016].
    National Health and Family Planning Commission Expert Committee on Rational Use of Medicines for Children Pharmaceutical Group
    Zhonghua Er Ke Za Zhi; 2018 Dec; 56(12):897-906. PubMed ID: 30518003
    [No Abstract]   [Full Text] [Related]  

  • 12. Bacterial meningitis. Rational selection and use of antibacterial drugs.
    Whitby M; Finch R
    Drugs; 1986 Mar; 31(3):266-78. PubMed ID: 3519175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute bacterial skin infections in pediatric medicine: current issues in presentation and treatment.
    Hedrick J
    Paediatr Drugs; 2003; 5 Suppl 1():35-46. PubMed ID: 14632104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacokinetics of fluconazole in superficial and systemic mycoses.
    Debruyne D
    Clin Pharmacokinet; 1997 Jul; 33(1):52-77. PubMed ID: 9250423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacokinetics of antibacterials in cerebrospinal fluid.
    Di Paolo A; Gori G; Tascini C; Danesi R; Del Tacca M
    Clin Pharmacokinet; 2013 Jul; 52(7):511-42. PubMed ID: 23605634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical pharmacokinetics of levofloxacin.
    Fish DN; Chow AT
    Clin Pharmacokinet; 1997 Feb; 32(2):101-19. PubMed ID: 9068926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefpodoxime proxetil: a review of its use in the management of bacterial infections in paediatric patients.
    Fulton B; Perry CM
    Paediatr Drugs; 2001; 3(2):137-58. PubMed ID: 11269640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population pharmacokinetics of itraconazole and its active metabolite hydroxy-itraconazole in paediatric cystic fibrosis and bone marrow transplant patients.
    Hennig S; Wainwright CE; Bell SC; Miller H; Friberg LE; Charles BG
    Clin Pharmacokinet; 2006; 45(11):1099-114. PubMed ID: 17048974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Voriconazole.
    Jeu L; Piacenti FJ; Lyakhovetskiy AG; Fung HB
    Clin Ther; 2003 May; 25(5):1321-81. PubMed ID: 12867215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrathecal Antibacterial and Antifungal Therapies.
    Nau R; Blei C; Eiffert H
    Clin Microbiol Rev; 2020 Jun; 33(3):. PubMed ID: 32349999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.